Noninvasive Imaging Estimation of Myocardial Iron Repletion Following Administration of Intravenous Iron: The Myocardial‐IRON Trial

BACKGROUND: Intravenous ferric carboxymaltose (FCM) improves symptoms, functional capacity, and quality of life in heart failure and iron deficiency. The mechanisms underlying these effects are not fully understood. The aim of this study was to examine changes in myocardial iron content after FCM ad...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Am Heart Assoc
Autors principals: Núñez, Julio, Miñana, Gema, Cardells, Ingrid, Palau, Patricia, Llàcer, Pau, Fácila, Lorenzo, Almenar, Luis, López‐Lereu, Maria P., Monmeneu, Jose V., Amiguet, Martina, González, Jessika, Serrano, Alicia, Montagud, Vicente, López‐Vilella, Raquel, Valero, Ernesto, García‐Blas, Sergio, Bodí, Vicent, de la Espriella‐Juan, Rafael, Lupón, Josep, Navarro, Jorge, Górriz, José Luis, Sanchis, Juan, Chorro, Francisco J., Comín‐Colet, Josep, Bayés‐Genís, Antoni
Format: Artigo
Idioma:Inglês
Publicat: John Wiley and Sons Inc. 2020
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7070181/
https://ncbi.nlm.nih.gov/pubmed/32067585
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/JAHA.119.014254
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars